Company intelligence / Profile preview
Medterra
Irvine, California, USA
- Ownership
- Private
- Employees
- ~100
- Development stage
- Other
01
Overview
Medterra is a market-leading producer of CBD and THC-free cannabinoid wellness products, rigorously third-party tested and sold direct-to-consumer and through retail channels. Medterra Pharmaceuticals is the R&D arm aiming to develop and clinically validate cannabinoid therapeutics, including research partnerships (e.g., Baylor College of Medicine), but does not have publicly disclosed clinical trial results at this time.
- Therapeutic areas
- NeurologyRheumatologyPsychiatry
- Modalities
- Small moleculeCombination product
- Industry
- Biotech
02
Drug pipeline
6 assets5 more assets in the full pipeline.
Request access →03
Partnerships
Baylor College of MedicineTexas Medical CenterHouston VA
Beyond the preview
Go deeper on Medterra.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Medterra.